Stock Taper Adjusted Net Investment Income: $0.32 per share, matching the dividend paid on December 31.
Net Asset Value (NAV): Declined to $11.52 per share from $12.06, primarily due to a lower valuation of Edmentum.
Total Investment Income: $77 million, a 4% decrease from the prior quarter.
Total Liabilities: $1.7 billion, with a net debt-to-equity ratio of 1.21:1, expected to decrease to approximately 0.9x post-asset sale.
Dividend: $0.32 per share declared for Q1 2026.
Asset Sale: Announced a $477 million sale of various assets, including Benevis and other concentrated positions, aimed at reducing PIK income and diversifying the portfolio.
Portfolio Composition: Post-sale, 81% of investments will be senior in nature, up from 75% the previous year. The top five positions will represent only 14% of the portfolio value.
Performance Fee Reduction: Pledged to reduce the performance fee from 20% to 15% until the end of 2026, with a commitment to maintain this lower rate permanently thereafter.
PIK Income: Expected to decrease by 20-25% as proceeds from the asset sale are redeployed.
Sustainable Dividend Rate: Anticipated to be approximately $0.25 per share per quarter beginning Q2 2026, supported by projected net investment income of around $0.27 per share.
Market Positioning: Plans to leverage cash from the asset sale for stock buybacks and to invest in higher-quality credit opportunities, particularly in a more favorable lending environment.
Growth Potential: Positive outlook on companies like UniTek, which is expected to grow significantly.
Declining NAV: The decline in NAV was primarily attributed to the performance of Edmentum and Affordable Care, with the latter expected to undergo restructuring due to operational underperformance.
Non-Accruals: Some investments, including Affordable Care and DCA, were moved to non-accrual status, though overall non-accruals remain low at 1.4% of the portfolio.
Market Volatility: AI-induced market volatility may impact M&A activity and the broader lending environment, necessitating a cautious approach to underwriting.
Asset Sale Process: The sale was competitive, led by Evercore, with multiple bidders involved. The assets were selected to reduce concentration and PIK income.
Valuation of Sold Assets: The sale was at a slight discount (94% of par), deemed fair for both parties, allowing NMFC to validate its internal marks while improving portfolio composition.
Future Strategy: NMFC aims to maintain a leverage target between 1 and 1.25, with plans to deploy sale proceeds into credit investments and potentially buy back undervalued stock. Overall, NMFC's Q4 2025 earnings call highlighted a strategic repositioning through asset sales, a commitment to shareholder returns, and a cautious yet optimistic outlook amidst market challenges.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT